A plasmid transformation system was developed for Bacillus polymyxa ATCC 12321 and derivatives of this strain. The method utilizes a penicillin-treated-cell technique to facilitate uptake of the plasmid DNA. Low-frequency transformation (10-6 per recipient cell) of plasmids pC194, pBD64, and pBC16 was accomplished with this method. Selection for the transformants was accomplished on both hypertonic and nonhypertonic selective media, with the highest rates of recovery occurring on a peptone-glucose-yeast extract medium containing 0.25 M sucrose. Several additional plasmids were shown to be capable of transferring their antibiotic resistance phenotypes to B. polymyxa through the use of a protoplast transformation procedure which allowed for a more efficient transfer of the plasmid DNA. However, cell walls could not be regenerated on the transformed protoplasts, and the transformants could not be subcultured from the original selective media.
Strains of Bacillus polymyxa can produce a number of useful and potentially useful compounds, including peptide antibiotics, proteases, and a wide variety of carbohydrateutilizing enzymes, such as P-amylase, ,-D-xylanase, pullulanase, glucose isomerase, and polygalacturonate lyase (12, 13, (35) (36) (37) . This bacterium has also been extensively tested as a source of 2,3-butylene glycol (23, 26, 38) , which can be converted into the feedstock chemical 1,3-butadiene.
For studies on the genetic control and enhanced production of these compounds, it would be useful to have a system for the transfer of genetic information within this species. Numerous methods of plasmid transfer between and within various Bacillus spp. have been reported. These include transduction (20, 25, 34) , spontaneous transfer by a conjugationlike process (15, 21, 32) , competent-cell plasmid transformation procedures for B. subtilis (10, 11) , protoplast transformation procedures (5, 7, 18, 19, 27, 28) , and a procedure developed for B. brevis involving exposing the cells to alkaline Tris hydrochloride (39) . However, no useful procedure for plasmid transfer has been reported for B. polymyxa. This study was initiated to develop such a procedure.
MATERIALS AND METHODS
Bacterial strains and plasmids. Table 1 lists the bacterial strains and plasmids used in this study.
Plasmid isolation procedures. Plasmid DNA was isolated from strains of B. subtilis by the procedure of Gryczan et al. (17) and by a modification of the procedure of Birnboim and Doly (4) . In the Birnboim-Doly procedure, the plasmidcontaining strain was grown overnight on brain heart infusion (Difco Laboratories, Detroit, Mich.) agar plates containing the appropriate antibiotic to select for the plasmid. Growth from this plate was used to inoculate 2.5 ml of brain heart infusion, which was incubated with shaking for 3.5 h at 35°C (mid to late log phase). A 0.75-ml portion of this culture was transferred to a 1.5-ml microcentrifuge tube and centrifuged for 15 s at room temperature. The cell pellet was suspended in 100 ,ul of protoplasting reagent (50 mM glu-cose, 0.2% lysozyme, 10 mM 1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid [ (7) . The cells were gently suspended in 0.5 to 1 ml of SMMP, and 0.5-ml portions of the suspension were mixed with 0.1 ml of a plasmid preparation dissolved in equal volumes of 2x SMM and TE buffer (10 mM Tris hydrochloride, 1 mM EDTA [pH 8.0]). A 1.5-ml portion of 40% polyethylene glycol 8000 in SMM was added, and the solution was gently mixed and kept for 2.5 min at 0°C, followed by a 5-min incubation period at 35°C. SMMP (5 ml) was added, and the protoplasts were pelleted by centrifugation at 3,000 x g for 15 min. The protoplasts were suspended in 1 ml of SMMP and incubated for 30 following concentrations to nonhypertonic media and PGYSA: 5 ,ug/ml for neomycin, kanamycin, erythromycin, and chloramphenicol; 15 ,ug/ml for tetracycline; and 35 ,ug/ml for streptomycin. For DM3 medium chloramphenicol and erythromycin were added to 10 ,ug/ml; tetracycline was added to 30 ,ug/ml; and kanamycin, neomycin, and streptomycin were added to 100 ,ug/ml. The plates were incubated at 35°C for 2 to 5 days. Protoplast formation and transformation of protoplasts. B.
polymyxa was protoplasted by using either mutanolysin or a combination of penicillin and lysozyme. In the penicillinlysozyme procedure the cells were grown and treated with penicillin as described above, collected by centrifugation, and suspended in 2.5 ml of SMMT (equal volumes of SMM and 2x Trypticase soy broth [BBL Microbiology Systems]). Lysozyme was added to 10 mg/ml, and the suspension was incubated for 1 h at 35°C. The protoplasts were collected by centrifugation for 15 min at 3,000 x g, gently suspended in 1 to 2.5 ml of SMMT, and transformed with plasmid DNA as described above. In the mutanolysin procedure 25 ml of Trypticase soy broth was inoculated with an overnight growth of B. polymyxa and incubated for approximately 3.5 h at 35-C (A540, 0.4). The cells were harvested by centrifugation at 10,000 x g for 10 min, and the pellet was gently suspended in 2.5 ml of SMMT. Mutanolysin was added to a concentration of 200 U/ml, and the suspension was incubated for 2 h at 35°C. The protoplasts were collected by centrifugation at 3,000 x g for 15 min, gently suspended in 1 to 2.5 ml of SMMT, and transformed with plasmid DNA as described above. Strains of B. subtilis were protoplasted and transformed with plasmid DNA by the procedure of Chang and Cohen (7) .
Development of a nonmucoid strain of B. polymyxa. A nonmucoid strain of B. polymyxa was developed for use in this study by mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine. B. polymyxa ATCC 12321 from an overnight growth on TSA was used to inoculate 100 ml of Trypticase soy broth in a 300-ml nephelometer flask to an A540 of 0.02. Cells were grown with shaking at 35°C until an A540 of 0.2 was reached. A 6.8-ml portion of the cell suspension was mixed with 3.2 ml of 0.25-mg/ml N-methyl-N'-nitro-N-nitrosoguanidine in 0.05 M sodium acetate (pH 5.5). The mixture was incubated without shaking for 30 min at 35°C before centrifugation at 3,000 x g for 8 min at room temperature. The pellet was washed once in 10 ml of 0.85% NaCl and suspended in 1 ml of minimal medium (26 (9, 24, 33) , and plasmid transformation of cells treated with alkaline Tris hydrochloride (39) were not successful with the B. polymyxa strains.
Transformation of protoplasted cells of B. polymyxa. Numerous attempts were also made to create a protoplast transformation system for B. polymyxa. Lysozyme was used in the prototype B. subtilis protoplast transformation procedure of Chang and Cohen (7) and in numerous other transformation procedures for Bacillus spp. However, lysozyme was ineffective when used with B. polymyxa, producing fewer than 5% protoplasts, as determined by microscopic analysis.
Two protoplasting procedures described in the Materials and Methods section were developed for use with B. polymyxa. The methods used either mutanolysin or a combination of penicillin and lysozyme. More than 90% protoplasts, as determined by microscopic analysis and growth on hypertonic (DM3) and nonhypertonic (TSA) media, were produced when the procedures were used with either strain ATCC 12321 or strain U121. Small colonies could be obtained by plating the protoplasted cultures on the hypertonic DM3 medium. However, cell walls could not be regenerated on the protoplasted cells, and the resulting colonies could not be transferred to any of several variations of hypertonic and nonhypertonic liquid or solid media, including the original DM3 medium. Numerous modifications to the regeneration media that have been utilized with other organisms were tried without success, including the use of different hypertonic agents, the use of agar overlays, the use of different incubation conditions, and the addition of cell wall precursors, autoclaved B. polymyxa cells and cell wall preparations, minerals, polyvinylpyrrolidone, gelatin, and nutritional growth factors (1, 2, 8 However, transformant colonies were obtained when penicillin-treated cells of B. polymyxa UI21 were exposed to DNA from plasmid pC194. Microscopic analysis of cells from the selective plates and transfers of the colonies to nonhypertonic selective media showed that the transformants were intact cells. We tested the effect of including divalent cations in the SMM buffer used during the plasmid uptake step of the transformation procedure. Transformations were done with B. polymyxa U121 as the recipient for approximately 1 ,ug of plasmid pC194 DNA. Selection was done on PGYA plus 5 ,ug of chloramphenicol per ml. The number of transformants per recipient cell was based on 4.2 x 107 CFU/ml of recipient cells. The original formulation of SMM, which included 20 mM MgCl2, produced more transformant colonies (90 CFU/ml, or 3.8 x 10-6/recipient cell) on PGYA selective plates than did SMM containing 20 mM CaCl2 instead (10 CFU/ml, or 4.2 x 10' recipient cell). DM3, and TSA (all containing 5 ,ug of chloramphenicol per ml) were tested, 100, 25, and 10 CFU of transformants per ml (1.9 x 10-6, 4.8 x 10-7, and 1.9 x 10-7 transformants per recipient cell, respectively, based on 5.2 x 107 CFU/ml of recipient cells) were produced, respectively. When PGYSA and PGYA (both containing 5 ,ug of chloramphenicol per ml) were tested, 506 and 123 CFU of transformants per ml (4.2 x 10-6 and 1.0 x 10-6 transformants per recipient cell, respectively, based on 1.2 x 108 CFU/ml of recipient cells) were produced, respectively. Controls run without plasmid DNA produced no colonies on selective media.
Plasmid DNA bands could be detected in B. polymyxa UI21 cells that had been transformed with plasmid pC194 by the penicillin-treated-cell technique (Fig. 1) (11) , and plasmid pBC16 was isolated from B. cereus (3) . Plasmid pBD64 is a chimeric plasmid developed from the S. aureus plasmids pC194 and pUB110 (16) .
Several additional plasmids originally isolated from S. aureus could apparently be transferred to B. polymyxa protoplasts. This procedure provided a higher transformation frequency than did the penicillin-injured-cell procedure, but cell walls could not be regenerated on the transformed cells and the colonies could not be subcultured. The complexity of the B. polymyxa cell wall (6, 30) and the highly efficient cell wall removal obtained with the mutanolysin and penicillin-lysozyme protoplasting procedures may help to explain the inability to develop a cell wall regeneration procedure. Regeneration of the cell wall may require the presence of some cell wall material, although purified B. polymyxa cell wall preparations had no effect on regeneration.
The penicillin-treated-cell transformation procedure provides a method for transferring plasmid DNA to B. polymyxa at a very low frequency (_10-6 transformants per recipient cell) and cannot be used effectively with selection techniques that produce spontaneous mutant colonies above this threshold. However, the technique should be useful in transferring to B. polymyxa plasmids that have been developed by cloning techniques in Escherichia coli or B. subtilis. The technique might also be useful in other species of grampositive organisms that have been resistant to other plasmid transfer techniques. Somewhat more efficient protoplast transformation methods showed that several additional plasmids could be transferred to B. polymyxa. Additional protoplast regeneration studies may prove useful with this bacterium.
